MXPA05005527A - Forma de dosis de alergeno. - Google Patents
Forma de dosis de alergeno.Info
- Publication number
- MXPA05005527A MXPA05005527A MXPA05005527A MXPA05005527A MXPA05005527A MX PA05005527 A MXPA05005527 A MX PA05005527A MX PA05005527 A MXPA05005527 A MX PA05005527A MX PA05005527 A MXPA05005527 A MX PA05005527A MX PA05005527 A MXPA05005527 A MX PA05005527A
- Authority
- MX
- Mexico
- Prior art keywords
- allergen
- dosage forms
- dosage form
- fast
- dispersing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
- A61J1/035—Blister-type containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
- A61K39/36—Allergens from pollen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2063—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes, or webs of flexible sheet material, e.g. in folded wrappers
- B65D75/28—Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by associating or interconnecting two or more sheets or blanks
- B65D75/30—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding
- B65D75/32—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents
- B65D75/325—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet being recessed, and the other being a flat not- rigid sheet, e.g. puncturable or peelable foil
- B65D75/327—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet being recessed, and the other being a flat not- rigid sheet, e.g. puncturable or peelable foil and forming several compartments
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/24—Immunology or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Pathology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Composite Materials (AREA)
- Mechanical Engineering (AREA)
- Biotechnology (AREA)
- Ophthalmology & Optometry (AREA)
- Pulmonology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
Abstract
La invencion proporciona productos farmaceuticos que contienen alergeno y en particular formas solidas de dosis de alergeno, de dispersion rapida. En particular, se proporcionan formas solidas de dosis, no comprimidas, de dispersion rapida, adecuadas para la administracion oromucosa, que comprende una matriz y al menos un alergeno. Las matrices adecuadas son gelatina, almidon y manitol. Tambien se proporcionan metodos para las formas de dosis.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42908602P | 2002-11-26 | 2002-11-26 | |
DKPA200201825 | 2002-11-26 | ||
DKPA200300279 | 2003-02-24 | ||
PCT/DK2003/000814 WO2004047794A2 (en) | 2002-11-26 | 2003-11-26 | An allergen dosage form |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA05005527A true MXPA05005527A (es) | 2006-04-05 |
Family
ID=32397517
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA05005528A MXPA05005528A (es) | 2002-11-26 | 2003-11-14 | Producto farmaceutico de alergeno. |
MXPA05005527A MXPA05005527A (es) | 2002-11-26 | 2003-11-26 | Forma de dosis de alergeno. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA05005528A MXPA05005528A (es) | 2002-11-26 | 2003-11-14 | Producto farmaceutico de alergeno. |
Country Status (17)
Country | Link |
---|---|
US (6) | US20040166123A1 (es) |
EP (2) | EP2436395B1 (es) |
JP (2) | JP5442924B2 (es) |
KR (2) | KR101281147B1 (es) |
CN (1) | CN101816787A (es) |
AU (3) | AU2003280324A1 (es) |
BR (1) | BR0316564A (es) |
CA (1) | CA2507551A1 (es) |
CO (1) | CO5690534A2 (es) |
HK (1) | HK1087008A1 (es) |
IL (1) | IL168733A (es) |
IS (1) | IS7894A (es) |
MX (2) | MXPA05005528A (es) |
NO (1) | NO20053142L (es) |
NZ (1) | NZ540850A (es) |
PL (1) | PL218350B1 (es) |
WO (2) | WO2004047793A1 (es) |
Families Citing this family (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2116257T3 (da) | 2000-08-09 | 2013-02-04 | Alk Abello As | Parenterale vaccineformuleringer og anvendelser deraf |
US7927600B2 (en) * | 2001-03-30 | 2011-04-19 | Emile Loria | Anti-allergic pharmaceutical composition containing at least one allergen and at least one antihistamine compound |
MXPA05005528A (es) * | 2002-11-26 | 2006-04-05 | Alk Abello As | Producto farmaceutico de alergeno. |
EP1718331A4 (en) | 2004-02-06 | 2009-11-11 | Greer Lab Inc | METHOD AND COMPOSITIONS FOR DOSING ALLERGENS |
US20060115499A1 (en) * | 2004-09-27 | 2006-06-01 | Alk-Abello A/S | Liquid allergy vaccine formulation for oromucosal administration |
EP2039349A1 (en) * | 2004-10-19 | 2009-03-25 | KRKA, tovarna zdravil, d.d., Novo mesto | Solid pharmaceutical composition comprising donepezil hydrochloride |
PL1812059T3 (pl) * | 2004-11-10 | 2010-10-29 | Alk Abello As | Profilaktyka alergii przez podanie na błonę śluzową szczepionki przeciw alergii |
US20060210590A1 (en) * | 2005-02-03 | 2006-09-21 | Alk-Abello A/S | Minor allergen control to increase safety of immunotherapy |
PT1868642E (pt) | 2005-03-18 | 2013-07-10 | Cytos Biotechnology Ag | Proteínas de fusão de alergénios de gato e suas utilizações |
RU2008117396A (ru) | 2005-10-04 | 2009-11-10 | Альк-Абелло А/С (Dk) | Твердая вакцинная композиция |
CN103933562A (zh) * | 2005-11-04 | 2014-07-23 | 爱尔开-阿贝优公司 | 用于口腔粘膜给药的液体变态反应性疫苗制剂的用途 |
KR20080070851A (ko) * | 2005-11-04 | 2008-07-31 | 알크-아벨로 에이/에스 | 구강점막 투여용 액상 알레르기 백신 제형의 용도 |
DK1966611T3 (da) | 2005-12-23 | 2012-09-10 | Alk Abello As | Fremgangsmåde til opløsningstest af farmaceutiske produkter |
EP1872792A1 (en) * | 2006-06-29 | 2008-01-02 | Biotech Tools S.A. | A method for the production of hydrolyzed allergen |
CN101678012A (zh) * | 2007-06-12 | 2010-03-24 | 阿尔克-阿贝洛有限公司 | 包含抗组胺药的过敏原剂型 |
GB0711683D0 (en) * | 2007-06-16 | 2007-07-25 | Enigma Diagnostics Ltd | Compositions |
WO2009034110A1 (en) | 2007-09-11 | 2009-03-19 | Kobenhavns Universitet | Prevention of type 1 diabetes by administration of gliadin |
DE202008006598U1 (de) * | 2008-04-11 | 2008-10-02 | Alk-Abelló A/S | Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung |
WO2010086989A1 (ja) | 2009-01-29 | 2010-08-05 | 日東電工株式会社 | 口腔内フィルム状基剤及び製剤 |
JP5588688B2 (ja) | 2010-01-28 | 2014-09-10 | 日東電工株式会社 | フィルム状製剤 |
WO2011112788A1 (en) * | 2010-03-12 | 2011-09-15 | Antigen Laboratories, Inc. | Methods of treating allergies with substantially phenol-free carriers |
JP5800527B2 (ja) * | 2010-03-30 | 2015-10-28 | 日東電工株式会社 | 安定化医薬組成物、安定化医薬組成物溶液製剤、フィルム状製剤及びフィルム状製剤の製造方法 |
JP5751868B2 (ja) | 2010-03-30 | 2015-07-22 | 日東電工株式会社 | フィルム状製剤及びその製造方法 |
CN103025303A (zh) * | 2010-04-30 | 2013-04-03 | 艾洛维特有限责任公司(Allovate,Llc) | 经由口腔粘膜变应性脱敏的方法、制品和试剂盒 |
US9724271B2 (en) * | 2010-04-30 | 2017-08-08 | Allovate, Llc | Methods and articles for preventing or reducing risk of developing a hyperallergenic immune system |
AU2011260233C1 (en) | 2010-06-03 | 2015-04-16 | Alk-Abello A/S | Pharmaceutical product comprising mite allergen extract(s) and a method for the manufacture thereof |
JP6061859B2 (ja) * | 2010-10-08 | 2017-01-18 | アール.ピー. シェーラー テクノロジーズ エルエルシー | デンプンを使用する経口ワクチン速溶性剤型 |
JP5875246B2 (ja) * | 2010-12-10 | 2016-03-02 | 日東電工株式会社 | シート状製剤及びシート状製剤の製造方法 |
JP5555148B2 (ja) * | 2010-12-10 | 2014-07-23 | 日東電工株式会社 | シート状製剤及びシート状製剤の製造方法 |
GB201104537D0 (en) * | 2011-03-17 | 2011-05-04 | Cambridge Entpr Ltd | Treatment for peanut allergy |
FI20115375A0 (fi) | 2011-04-18 | 2011-04-18 | Teknologian Tutkimuskeskus Vtt Oy | Uudet hypoallergeenit |
FI20115374A0 (fi) | 2011-04-18 | 2011-04-18 | Teknologian Tutkimuskeskus Vtt Oy | Uudet hypoallergeenit |
JP5952634B2 (ja) * | 2011-05-20 | 2016-07-13 | 日東電工株式会社 | 医薬組成物およびその製造方法 |
CA2777431A1 (en) * | 2011-05-20 | 2012-11-20 | Nitto Denko Corporation | Pharmaceutical composition and method for producing the same |
JP5931449B2 (ja) * | 2012-01-11 | 2016-06-08 | 日東電工株式会社 | 医薬組成物及びその製造方法 |
JP5841433B2 (ja) | 2012-01-11 | 2016-01-13 | 日東電工株式会社 | 口腔内フィルム状基剤及び製剤 |
MX2014009285A (es) | 2012-02-07 | 2015-02-04 | Jolla Inst Allergy Immunolog | Alergenos del fleo de los prados y metodos y usos para la modulacion de respuesta inmune. |
WO2013173697A1 (en) * | 2012-05-17 | 2013-11-21 | The Johns Hopkins University | Orally dissolving thin films containing allergens and methods of making and use |
JP2014034530A (ja) * | 2012-08-07 | 2014-02-24 | Nitto Denko Corp | アレルゲン含有シート状製剤及びその製造方法 |
SG11201500889TA (en) | 2012-08-21 | 2015-03-30 | Sanofi Sa | Methods for treating or preventing asthma by administering an il-4r antagonist |
CN103215236A (zh) * | 2013-01-29 | 2013-07-24 | 中国科学院昆明动物研究所 | 尘螨过敏原Derf8和Derf20及其基因和应用 |
WO2014159609A1 (en) | 2013-03-14 | 2014-10-02 | Allergen Research Corporation | Peanut formulations and uses thereof |
ES2503516B1 (es) * | 2013-04-03 | 2015-09-09 | Inmunotek, S.L. | Complejo inmunogénico para vacunación y método de obtención |
TWI633891B (zh) | 2013-06-04 | 2018-09-01 | 再生元醫藥公司 | 藉由投與il-4r抑制劑以治療過敏及增強過敏原-特異之免疫療法的方法 |
AU2014321402B2 (en) | 2013-09-19 | 2019-07-25 | Allovate, Llc | Toothpaste for delivering allergens to oral mucosa |
EP2952200A1 (en) | 2014-06-04 | 2015-12-09 | Alk-Abelló A/S | Allergen for prophylactic treatment of allergy |
KR102193599B1 (ko) | 2014-09-17 | 2020-12-21 | 스티어라이프 인디아 프라이빗 리미티드 | 발포성 조성물 및 이의 제조방법 |
WO2016077675A1 (en) | 2014-11-14 | 2016-05-19 | Sanofi Biotechnology | Methods for treating chronic sinusitis with nasal polyps by administering an il-4r antagonist |
WO2017098481A1 (en) | 2015-12-12 | 2017-06-15 | Steerlife India Private Limited | Effervescent compositions of metformin and processes for preparation thereof |
MA46098A (fr) | 2016-09-01 | 2019-07-10 | Regeneron Pharma | Méthodes de prévention ou de traitement de l'allergie par administration d'un antagoniste d'il-4 r |
WO2018057776A1 (en) | 2016-09-22 | 2018-03-29 | Regeneron Pharmaceuticals, Inc. | Methods for treating severe atopic dermatitis by administering an il-4r inhibitor |
US10359292B2 (en) | 2017-04-05 | 2019-07-23 | International Business Machines Corporation | Deep learning allergen mapping |
US10517834B2 (en) * | 2017-05-16 | 2019-12-31 | Owen Murray | Fast dissolving tablet formulations and methods of making thereof |
EP3672600A4 (en) | 2017-08-21 | 2021-05-19 | Glycom A/S | SYNTHETIC COMPOSITION TO REDUCE ALLERGY SYMPTOMS |
CA3079946A1 (en) | 2017-10-30 | 2019-05-09 | Sanofi Biotechnology | Methods for treating or preventing asthma by administering an il-4r antagonist |
FI128016B (en) | 2018-01-04 | 2019-07-31 | Desentum Oy | Recombinant hypoallergenic Ecu c1 polypeptides for use in horse allergy immunotherapy |
AU2019310602A1 (en) | 2018-07-27 | 2021-02-04 | Societe Des Produits Nestle S.A. | Oral immunotherapy unit dose dispensing systems and methods |
WO2020037152A1 (en) * | 2018-08-16 | 2020-02-20 | Biohaven Therapeutics Ltd. | Use of riluzole oral disintigrating tablets for treating diseases |
EP3836801A4 (en) * | 2018-08-16 | 2022-05-18 | Société des Produits Nestlé S.A. | ORAL PEANUT DESENSITIZATION IMMUNOTHERAPY WITH MAINTENANCE DOSE |
JP7496356B2 (ja) * | 2018-11-30 | 2024-06-06 | ジェネンテック, インコーポレイテッド | 凍結乾燥薬剤内の夾雑物を同定するためのレーザー誘起破壊分光法 |
WO2020191346A1 (en) | 2019-03-21 | 2020-09-24 | Regeneron Pharmaceuticals, Inc. | Combination of il-4/il-13 pathway inhibitors and plasma cell ablation for treating allergy |
US11229673B2 (en) | 2019-05-10 | 2022-01-25 | Société des Produits Nestlé S.A. | Methods for improving the quality of life of a patient with a peanut allergy |
CA3147113A1 (en) | 2019-08-05 | 2021-02-11 | Regeneron Pharmaceuticals, Inc. | Methods for treating atopic dermatitis by administering an il-4r antagonist |
SG11202113312VA (en) | 2019-08-05 | 2021-12-30 | Regeneron Pharma | Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an il-4r antagonist |
JP7050734B2 (ja) * | 2019-09-30 | 2022-04-08 | 鳥居薬品株式会社 | 舌下アレルゲン免疫療法におけるフィルム製剤 |
US11672761B2 (en) | 2020-11-16 | 2023-06-13 | Orcosa Inc. | Rapidly infusing platform and compositions for therapeutic treatment in humans |
Family Cites Families (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US44351A (en) * | 1864-09-20 | Gang-plow | ||
US107208A (en) * | 1870-09-06 | Improvement in apparatus for the manufacture of illuminating-gas | ||
US57856A (en) * | 1866-09-11 | Improvement in cultivators | ||
US271079A (en) * | 1883-01-23 | Grain weigher and tally | ||
US278877A (en) * | 1883-06-05 | Ribbon or label holder for hats | ||
US346622A (en) * | 1886-08-03 | Bedstead | ||
US2378383A (en) * | 1942-10-17 | 1945-06-19 | Brush Dev Co | Transient signal recordingreproducing device |
US3816314A (en) * | 1972-05-31 | 1974-06-11 | Exxon Research Engineering Co | Block copolymers of unsaturated ester and a nitrogen containing monomer as v.i.improving and dispersant additives for oils |
DD107208A1 (es) | 1973-06-04 | 1974-07-20 | ||
GB1548022A (en) * | 1976-10-06 | 1979-07-04 | Wyeth John & Brother Ltd | Pharmaceutial dosage forms |
US4371513A (en) * | 1977-03-25 | 1983-02-01 | W. R. Grace & Co. | Alumina compositions |
US5811128A (en) * | 1986-10-24 | 1998-09-22 | Southern Research Institute | Method for oral or rectal delivery of microencapsulated vaccines and compositions therefor |
US4822611A (en) | 1986-12-09 | 1989-04-18 | Immunotec, Inc. | Oral hyposensitization in the treatment of allergies |
US5244663A (en) * | 1987-01-28 | 1993-09-14 | Medibrevex | Therapeutic method against allergy |
FR2609895B1 (fr) | 1987-01-28 | 1991-06-28 | Bruttmann Georges | Nouvelles formes galeniques d'allergenes pour administration par voie per- et sub-linguale |
IT1217628B (it) * | 1988-05-18 | 1990-03-30 | Neo Abello Spa | Forma farmaceutica e supporto per la somministrazione di estratti ellergenici |
US5215756A (en) * | 1989-12-22 | 1993-06-01 | Gole Dilip J | Preparation of pharmaceutical and other matrix systems by solid-state dissolution |
JPH0537070A (ja) | 1991-07-26 | 1993-02-12 | Sharp Corp | 分布帰還型半導体レーザ素子の製造方法 |
JPH0597672A (ja) * | 1991-10-08 | 1993-04-20 | Terumo Corp | アミド誘導体含有固形製剤およびその製造方法 |
AU3949093A (en) * | 1992-03-31 | 1993-11-08 | Benzon Pharma A/S | A pharmaceutical formulation |
IL105553A (en) | 1992-05-06 | 1998-01-04 | Janssen Pharmaceutica Inc | Solid dosage forms consisting of a porous network of matrix that releases a substance that dissipates rapidly in water |
US5343762A (en) | 1992-10-05 | 1994-09-06 | Rosemount Inc. | Vortex flowmeter |
US5343672A (en) | 1992-12-01 | 1994-09-06 | Scherer Ltd R P | Method for manufacturing freeze dried dosages in a multilaminate blister pack |
US5762961A (en) * | 1996-02-09 | 1998-06-09 | Quadrant Holdings Cambridge Ltd. | Rapidly soluble oral solid dosage forms, methods of making same, and compositions thereof |
US6074673A (en) | 1996-04-22 | 2000-06-13 | Guillen; Manuel | Slow-release, self-absorbing, drug delivery system |
JP2832885B2 (ja) | 1996-09-02 | 1998-12-09 | 株式会社林原生物化学研究所 | スギ花粉アレルゲン |
CN100364611C (zh) | 1996-11-13 | 2008-01-30 | 明治乳业株式会社 | 肽基免疫治疗剂 |
AU736912B2 (en) * | 1997-02-20 | 2001-08-02 | Therics, Inc. | Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same |
DE19713001A1 (de) * | 1997-03-27 | 1998-10-01 | Merck Patent Gmbh | Graminaenpollenallergenmutanten zur spezifischen Immuntherapie, deren Herstellung und Verwendung |
US20020197321A1 (en) * | 1997-10-27 | 2002-12-26 | Harry Seager | Solid dispersing vaccine composition for oral delivery |
GB9722682D0 (en) | 1997-10-27 | 1997-12-24 | Scherer Ltd R P | Pharmaceutical products |
AU749749B2 (en) | 1998-03-16 | 2002-07-04 | Alk-Abello A/S | Mutant recombinant allergens |
GB9819484D0 (en) | 1998-09-07 | 1998-10-28 | Univ Bristol | Therapeutic agents |
GB9901819D0 (en) * | 1999-01-27 | 1999-03-17 | Scherer Corp R P | Pharmaceutical compositions |
FR2790387B1 (fr) | 1999-03-01 | 2001-05-18 | Prographarm Laboratoires | Comprime orodispersible presentant une faible friabilite et son procede de preparation |
GB9904629D0 (en) * | 1999-03-02 | 1999-04-21 | Danbiosyst Uk | Oral drug delivery system |
FR2791569B1 (fr) | 1999-03-31 | 2003-05-09 | Pf Medicament | Composition ou structure microporeuse expansee isotrope a dissolution rapide a usage pharmaceutique, veterinaire, dietetique, alimentaire ou cosmetique et son procede d'obtention |
GB9908014D0 (en) * | 1999-04-08 | 1999-06-02 | Scherer Corp R P | Pharmaceutical compositions |
SE9901857D0 (sv) * | 1999-05-21 | 1999-05-21 | Anders Cedergren | Karl Fischer reagent |
US20010031262A1 (en) | 1999-12-06 | 2001-10-18 | Michael Caplan | Controlled delivery of antigens |
GB0000891D0 (en) | 2000-01-14 | 2000-03-08 | Allergy Therapeutics Ltd | Formulation |
GB0002386D0 (en) * | 2000-02-02 | 2000-03-22 | Novartis Nutrition Ag | Therapeutic composition |
US6458968B2 (en) * | 2000-06-09 | 2002-10-01 | Rensselaer Polytechnic Institute | Dithiocarboxylic ester synthetic process |
GB0020089D0 (en) * | 2000-08-15 | 2000-10-04 | Smithkline Beecham Biolog | Vaccine Composition |
NZ525820A (en) | 2000-11-16 | 2005-01-28 | Alk Abello As | Mutant allergens |
US6733781B2 (en) * | 2000-12-06 | 2004-05-11 | Wyeth | Fast dissolving tablet |
GB2378383A (en) | 2001-06-06 | 2003-02-12 | Gursharan Moonga | Nasal delivery of pharmaceutical compositions in powder form |
DE10137232A1 (de) * | 2001-07-30 | 2003-02-20 | Pierre Foss | Allergenträger |
AU2003223934A1 (en) | 2002-05-16 | 2003-12-02 | Alk Abello A/S | Recombinant bet. v. 1. allergen mutants, methods and process thereof |
MXPA05005528A (es) | 2002-11-26 | 2006-04-05 | Alk Abello As | Producto farmaceutico de alergeno. |
US8012505B2 (en) * | 2003-02-28 | 2011-09-06 | Alk-Abello A/S | Dosage form having a saccharide matrix |
DE202008006598U1 (de) * | 2008-04-11 | 2008-10-02 | Alk-Abelló A/S | Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung |
-
2003
- 2003-11-14 MX MXPA05005528A patent/MXPA05005528A/es active IP Right Grant
- 2003-11-14 AU AU2003280324A patent/AU2003280324A1/en not_active Abandoned
- 2003-11-14 WO PCT/DK2003/000784 patent/WO2004047793A1/en not_active Application Discontinuation
- 2003-11-26 KR KR1020127002506A patent/KR101281147B1/ko active IP Right Grant
- 2003-11-26 JP JP2005510223A patent/JP5442924B2/ja not_active Expired - Lifetime
- 2003-11-26 AU AU2003283207A patent/AU2003283207C1/en not_active Expired
- 2003-11-26 CN CN201010150697A patent/CN101816787A/zh active Pending
- 2003-11-26 EP EP11181642.7A patent/EP2436395B1/en not_active Expired - Lifetime
- 2003-11-26 EP EP03775108A patent/EP1567123A2/en not_active Withdrawn
- 2003-11-26 WO PCT/DK2003/000814 patent/WO2004047794A2/en active Application Filing
- 2003-11-26 CA CA002507551A patent/CA2507551A1/en not_active Abandoned
- 2003-11-26 KR KR1020057009585A patent/KR20050103187A/ko not_active Application Discontinuation
- 2003-11-26 BR BR0316564-7A patent/BR0316564A/pt not_active Application Discontinuation
- 2003-11-26 MX MXPA05005527A patent/MXPA05005527A/es not_active Application Discontinuation
- 2003-11-26 NZ NZ540850A patent/NZ540850A/en not_active IP Right Cessation
- 2003-11-26 US US10/723,308 patent/US20040166123A1/en not_active Abandoned
- 2003-11-26 PL PL377745A patent/PL218350B1/pl unknown
-
2005
- 2005-05-23 IL IL168733A patent/IL168733A/en not_active IP Right Cessation
- 2005-06-14 IS IS7894A patent/IS7894A/is unknown
- 2005-06-24 CO CO05062162A patent/CO5690534A2/es not_active Application Discontinuation
- 2005-06-27 NO NO20053142A patent/NO20053142L/no not_active Application Discontinuation
-
2006
- 2006-06-21 HK HK06107051.5A patent/HK1087008A1/xx not_active IP Right Cessation
-
2008
- 2008-04-04 US US12/098,150 patent/US9415015B2/en active Active
- 2008-04-04 US US12/098,191 patent/US8329196B2/en active Active
-
2010
- 2010-03-03 AU AU2010200798A patent/AU2010200798B2/en not_active Expired
-
2011
- 2011-01-06 JP JP2011001387A patent/JP5622594B2/ja not_active Expired - Fee Related
-
2014
- 2014-05-27 US US14/287,920 patent/US9408805B2/en not_active Expired - Fee Related
-
2016
- 2016-07-06 US US15/202,722 patent/US10080719B2/en not_active Expired - Lifetime
-
2017
- 2017-09-08 US US15/699,116 patent/US10471008B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA05005527A (es) | Forma de dosis de alergeno. | |
HK1069126A1 (en) | Drug microparticles | |
AU2003210243A1 (en) | Method for systemic drug delivery through the nail | |
HK1046244A1 (en) | Controlled release and taste masking oral pharmaceutical compositions. | |
AU2003266133A1 (en) | Materials and methods for drug delivery and uptake | |
IL131651A0 (en) | A pharmaceutical formulation containing benzimidazoles with amino acid/caclodextrin combinations and a process for producing the same | |
WO2000051593A3 (en) | Oral drug delivery system | |
WO2004075875A8 (en) | Dosage form having a saccharide matrix | |
MXPA03009391A (es) | METODO PARA FABRICAR UNA COMPOSICIoN FARMACEUTICA DE DOSIS BAJA. | |
AU2003297199A8 (en) | Human chondroitinase glycoprotein (chasegp), process for preparing the same, and pharmaceutical compositions comprising thereof | |
AU2003300469A1 (en) | Methods for making pharmaceutical dosage forms containing active cushioning components | |
WO2005007137A3 (de) | Ambroxolhaltige tabletten | |
DE60102590D1 (de) | Darreichungsformen zur behandlung von oralen mykosen | |
MXPA03008420A (es) | Forma farmaceutica solida oralmente dispersa. | |
CA2387844A1 (en) | Treatment of emphysema using rar selective retinoid antagonists | |
ECSP055895A (es) | Producto farmacéutico de alergeno | |
AU2003272260A1 (en) | Verifiable absorption drug delivery form based on cyclodextrins | |
UA87152C2 (ru) | Твердая фармацевтическая композиция, содержащая миртазапин, и способ ее получения | |
AU2003226746A1 (en) | Intravaginal matrix drug delivery devices | |
MY135825A (en) | Tablets comprising flavourings and/or aromatizing substances | |
AU2003291758A1 (en) | Waxy matrix dosage forms | |
PL378106A1 (pl) | Sposób wytwarzania zawierającej fibrat kompozycji farmaceutycznej w postaci tabletek oraz tabletki otrzymane tym sposobem | |
CA2473718A1 (en) | Immediate-release pharmaceutical dosage form comprising polymorphous tibolone | |
AU2003258578A1 (en) | Filling device for capsules, in particular medicament capsules | |
ZA200204331B (en) | Pharmaceutical composition for controlled drug delivery system. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |